SCHEMBL19690428

SCHEMBL19690428

Nc1c([N+](=O)[O-])ccc(N2Cc3ccc(F)cc3C2)c1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.46
MAPT P10636 8/20 0.42
ALDH1A1 P00352 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
ATM Q13315 1/20 0.42
ADORA2A P29274 1/20 0.37
LMNA P02545 3/20 0.36
NPSR1 Q6W5P4 1/20 0.36
PDE7A Q13946 1/20 0.36
SIRT6 Q8N6T7 1/20 0.36
MAPK1 P28482 2/20 0.36
DPP9 Q86TI2 3/20 0.35
DPP4 P27487 2/20 0.35
DPP8 Q6V1X1 2/20 0.35
DPP7 Q9UHL4 2/20 0.35
PKM P14618 1/20 0.35
POLB P06746 2/20 0.34
IP6K1 Q92551 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19690481 0.90 RAB9A (0.56) RAB9AMAPTALDH1A1TDP1ATM
SCHEMBL19690296 0.90 RAB9A (0.56) RAB9AMAPTALDH1A1TDP1ATM
SCHEMBL19700189 0.88 TSHR (0.41) RAB9AMAPTALDH1A1TDP1LMNA
SCHEMBL19690305 0.85 MAPT (0.45) RAB9AMAPTALDH1A1LMNANPSR1
SCHEMBL19690443 0.78 LMNA (0.58) RAB9AMAPTALDH1A1TDP1ATM
SCHEMBL19690307 0.77 LMNA (0.46) RAB9AMAPTALDH1A1TDP1LMNA
SCHEMBL19690477 0.77 LMNA (0.46) RAB9AMAPTALDH1A1TDP1LMNA
SCHEMBL939398 0.76 ALDH1A1 (0.68) MAPTALDH1A1LMNAMAPK1PKM
SCHEMBL2892379 0.76 MAPT (0.55) RAB9AMAPTALDH1A1ATMLMNA
SCHEMBL21031716 0.75 ALDH1A1 (0.67) MAPTALDH1A1TDP1LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858900-B2 Fluorinated 2-amino-4-(substituted amino)phenyl carbamate derivatives OCUTERRA THERAPEUTICS, INC. (US) 2024-01-02 US disclosed
US-11858900-B2 Fluorinated 2-amino-4-(substituted amino)phenyl carbamate derivatives OCUTERRA THERAPEUTICS, INC. (US) 2024-01-02 US disclosed
US-20210309612-A1 FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES OCUTERRA THERAPEUTICS, INC. 2021-10-07 US disclosed
EP-3468947-A1 FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES SciFluor Life Sciences, Inc. (US) 2019-04-17 EP disclosed
US-20170355679-A1 FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES SCIFLUOR LIFE SCIENCES, INC. 2017-12-14 US disclosed
WO-2017214539-A1 FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES SCIFLUOR LIFE SCIENCES, INC. (US) 2017-12-14 WO disclosed
US-20170355679-A1 FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES SCIFLUOR LIFE SCIENCES, INC. 2017-12-14 US disclosed
WO-2017214539-A1 FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES SCIFLUOR LIFE SCIENCES, INC. (US) 2017-12-14 WO disclosed
US-20170355679-A1 FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES SCIFLUOR LIFE SCIENCES, INC. 2017-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170355679-A1 FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES KCNQ2, KCNQ1, KCNQ3 RAB9A 1834/4885MAPT 2123/4885ALDH1A1 4495/4885
US-11858900-B2 Fluorinated 2-amino-4-(substituted amino)phenyl carbamate derivatives KCNQ2, KCNQ1, KCNQ3 RAB9A 1834/4885MAPT 2123/4885ALDH1A1 4495/4885
US-20210309612-A1 FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES KCNQ2, KCNQ1, KCNQ3 RAB9A 1834/4885MAPT 2123/4885ALDH1A1 4495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.